Complete Genomics has raised $45 million in a Series D funding round.
There are excellent hypertension treatments available but many Americans don’t know they have the condition and aren’t being treated.
A new study describes the relatively high doses of ionizing radiation being received by many Americans as a result of imaging procedures.
Pharmacogenomics is at the forefront of personalized medicine development. Recent research indicates promise in anti-platelet therapy guidance.
A commentary on Medicare’s experience in attempting to improve the quality of heart failure care demonstrates just how hard it may be to get better outcomes and lower cost.
A Financial Times article details the British National Health Service’s struggles to implement a new health information system.
Earlier this year the California Department of Insurance was asked to allow a greater than 20% increase in workers’ compensation premiums. The Department’s response provides some interesting observations on the state of workers’ compensation medical cost control efforts.
USA Today published an article on the federal end-stage renal disease program. The problems are typical of most government health programs.
Aon has estimated that private insurers health costs will increase at over 10% next year.
An Op-ed suggests we spend too little on healthcare. That may depend on who is paying.